Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ivermectin Cream 1% for Ocular Demodex Infestation
NCT05213585Phase 3Completed
- Sponsor
- Helm Vision Group
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin in demodicosis, sponsored by Helm Vision Group. Started Aug 2021; status: completed.
02
Drugs
ivermectin
03
Conditions
demodicosis
Beyond the preview
Go deeper on NCT05213585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05213585.